Top-News

Elanco Animal Health Aktie News

Aktie
WKN:  A2N6BH ISIN:  US28414H1032 US-Symbol:  ELAN Branche:  Pharmazeutika Land:  USA
21,90 $
-0,09 $
-0,41%
18,809 € 20:03:44 Uhr
Depot/Watchlist
Marktkapitalisierung *
8,97 Mrd. €
Streubesitz
-
KGV
17,81
Index-Zuordnung
-

Elanco Animal Health News

05.06.25 - PR Newswire
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief PR Newswire
28.05.25 - PR Newswire
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer PR Newswire
16.05.25 - PR Newswire
Elanco to Participate in the Upcoming Investor Conferences
Elanco to Participate in the Upcoming Investor Conferences PR Newswire
07.05.25 - PR Newswire
Elanco Animal Health Reports First Quarter 2025 Results
Elanco Animal Health Reports First Quarter 2025 Results PR Newswire
05.05.25 - PR Newswire
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown
Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown PR Newswire
22.04.25 - PR Newswire
Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day
Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus ...
10.04.25 - PR Newswire
Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement
Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement PR Newswire
17.03.25 - PR Newswire
Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets
Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets PR Newswire
25.02.25 - PR Newswire
Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle
Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle PR Newswire
25.02.25 - PR Newswire
Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results
Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results PR Newswire
21.02.25 - PR Newswire
Elanco to Participate in Upcoming Investor Conferences
Elanco to Participate in Upcoming Investor Conferences PR Newswire
20.02.25 - PR Newswire
Elanco Launches Pet Protect™ From the Makers of Advantage®: Veterinarian-Formulated Supplements for Complete Pet Wellness
Elanco Launches Pet Protect™ From the Makers of Advantage®: Veterinarian-​Formulated Supplements for Complete Pet Wellness PR Newswire
13.02.25 - PR Newswire
Elanco Reinforces Commitment to Veterinary and Pet Owner Education
Elanco Reinforces Commitment to Veterinary and Pet Owner Education PR Newswire
04.02.25 - PR Newswire
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement PR Newswire
27.01.25 - PR Newswire
Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal
Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal PR Newswire
23.01.25 - PR Newswire
Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest[i] Parasite Protection of Its Kind
Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest[i] Parasite Protection of Its Kind PR Newswire
19.12.24 - PR Newswire
Elanco to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Elanco to Participate in the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire
09.12.24 - PR Newswire
NYSE: ELAN Lawsuit Alert: Investors who lost money with Elanco Animal Health Incorporated shares should contact the Shareholders Foundation
NYSE: ELAN Lawsuit Alert: Investors who lost money with Elanco Animal Health Incorporated shares should contact the Shareholders Foundation PR Newswire
06.12.24 - PR Newswire
Class Action Filed Against Elanco Animal Health Incorporated (ELAN) - December 6, 2024 Deadline to Join - Contact Levi & Korsinsky
Class Action Filed Against Elanco Animal Health Incorporated (ELAN) - December 6, 2024 Deadline to Join - Contact Levi & Korsinsky PR Newswire
06.12.24 - PR Newswire
ELAN Deadline: ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit
ELAN Deadline: ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +0,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »